General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
1. Opening Hook
A 52% net profit jump, a ₹5bn capex pipeline, and a company that’s suddenly convinced it needs ₹20,000 crores to play in Vadhvan. Aegis Vopak’s June call was less earnings presentation, more expansion manifesto—one where management spent far more time on what it plans to build than what it actually did. The numbers were solid. The ambition was giddy. The execution track record? That’s where it gets interesting.
2. At a Glance
Revenue: ₹923.1 Cr, +17% YoY
Growth moderately paced; liquid segment (the “fastest-growing”) added 27.8%, but that’s partly capacity fill, not pricing power.
Operating EBITDA: ₹686.5 Cr, +19.4%
Margins expanded as new capacity came online and operating leverage kicked in; nothing extraordinary on pricing or cost.
Net Profit: ₹341.9 Cr, +52.1%
A sharp jump, but driven by lower interest expense (₹110 Cr vs ₹193 Cr prior year)—operational leverage plus refinancing, not a demand boom.
Capex Roadmap: ~USD 1.2bn by FY27, ~USD 5bn by 2030
Management is accelerating. That’s not a typo. Vadhvan alone carries a potential INR 20,000 Cr outlay, pending approvals.
LPG Throughput Crisis: Down 50% in March, recovered to 30–35% by May
Middle East shipping disruptions. Management expects “back on track” from Q2. Mostly a blip, but it happened.
Dividend: ₹0.2/share (2.0% on face value)
Minimal. Management is clearly hoarding cash for the capex spree.
3. Management’s Key Commentary
On Capacity and Growth
“We are not product-dependent, therefore not customer-dependent… not even trade-dependent.”
(Translation: We’re trying to say we’re diversified. What we’re actually saying is we’re not anchored to high-margin contracts—we’re a gun for hire.)
On the Execution Edge
“Construct in-house our own infrastructure cheapest, quickest.”
(Translation: Our parent company builds things. That’s our moat. It’s not a small advantage, but it’s not—you know—proprietary software or a brand.)
On Liquid Terminal Pricing
“INR 3,000 generally per CBM is what is regarded as a very good blended earning from liquid terminals.”
(Translation: That’s the benchmark. They’re calling it out, which means they’re probably hitting it or close to it. The fact that they named a number is usually a good sign; vagueness is the enemy of clarity.)
On LPG Import Disruption
“Ships were stranded in Strait of Hormuz since the war began in March… generally a 50% down… by May improved to 30–35% down.”
(Translation: We had a 50% volume crater in a strategically critical month. We’re calling it ‘improved’ now that it’s only 35% down. The normalization story is hopeful, but the disruption was real.)
On Future Gas Mix
“Generally we do a 30% to 40% growth… throughput… year-on-year… gas to be more dominant going forward, roughly 55–45 or 60–40.”
(Translation: We’re guessing gas will grow faster and become the bigger pie. No commitment, no timeline, but that’s the thesis.)
On Vadhvan and Future Equity
“Finished our second phase QIP, that is equity dilution… potential outlay ~INR 20,000 cr, subject to approvals/land allocation.”
(Translation: We’ve already diluted shareholders once. We’re signalling we’ll do it again for mega-projects. The ‘subject to approvals’ is doing a lot of heavy lifting—Vadhvan is not a done deal.)
4. Numbers Decoded
| Metric | FY26 | Q4 FY26 | YoY Change |
|---|---|---|---|
| Revenue from Operations (₹ Cr) | 923.1 | 243.5 | +17% / +22.2% |
| Liquid Terminaling (₹ Cr) | 440.5 | 121.1 | +27.8% / +31% |
| Gas Terminaling (₹ Cr) | 482.6 | 122.4 | +8.6% / +14.6% |
| Operating EBITDA (₹ Cr) | 686.5 | 179.2 | +19.4% / +24.2% |
| Net Profit (₹ Cr) | 341.9 | 73.9 | +52.1% / +15.3% |
| Operating Margin (%) | 74.4% | 73.6% | ~flat |
| Interest Expense (₹ Cr) | 110 | 41 | ↓ 43% YoY (FY25: ₹193 Cr) |
| Capex (FY26, actual) | ~₹3,077 Cr (investing cash flow) | — | — |
| Net Debt (₹ Cr, approx) | Borrowings ₹3,731 less cash | — | Gearing ~0.87x (debt-to-equity) |
Liquid Storage Capacity (MMCbM) — 1.70 (as of Dec 2025, up from 0.56 in Nov 2021; 3.75x growth since JV formation).
LPG Static Capacity (MT) — 225,800 (up from 67,000; 4.5x growth).
Gas Throughput (MTPA) — 3.9 (FY26) vs 3.3 prior; quarterly Q4 run-rate ~1.0 MT.
5. Analyst Questions
Q: How confident is the JNPT liquid ramp?
Management: “Phase-1 liquid operational Q1 FY27… unlike other ports, [JNPT] has more demand… quite a good realization from the time it commissions.”
(The question dodged the risk of a delayed ramp; the answer sidestepped by touting demand instead of confirming the timeline. “Quite a good realization” is not a volume guarantee.)
Q: Pipavav’s take-or-pay on liquid—who’s the customer?
Management: “Secured 15-year take-or-pay with a leading conglomerate for petroleum products; >0.5 MTPA committed.”
(A 15-year contract with >0.5 MTPA is a real anchor. Refusing to name the customer is normal; the contract existence is solid.)
Q: What’s the ammonia strategy—is it core or a bet?
Management: “India’s first independent ammonia terminal… backed by 15-year take-or-pay with Hindustan Zinc for upcoming DAP plant expected H1 FY27… ITOCHU acquired 10% in ammonia subsidiary.”
(Ammonia is being positioned as strategic, backed by a global partner taking a stake. But it’s one terminal, one anchor customer. It’s real, but it’s not yet a business line.)
6. Guidance & Outlook
Capex Roadmap (Management’s stated targets)
- FY27: ~USD 1.2bn (~₹10,000 Cr)
- By 2030: ~USD 5bn pipeline
- FY28 indication: ~₹5,000 Crores (management said “still being summed up”)
- Phasing: Accelerating cadence: $200M → $600M → $1.2bn, with larger capex in the last two years to 2030.
Funding Strategy (Management’s stated approach)
- Debt target: Gearing ~0.6x (currently 0.87x; refinancing and equity raises expected to bring it down).
- FY26 debt raised: ₹1,690 Cr (Series 1 and 2 NCDs, NSE-listed).
- Future equity: Signalled a potential third QIP (no size/timeline disclosed); Vadhvan contingent on approvals.
Throughput Assumptions (Management’s articulated growth)
- LPG import recovery: From Q2 FY27, “things should be back on track” after Middle East disruptions.
- 30–40% annual throughput growth: Management’s typical expectation year-on-year.
- Gas mix shift: Expected to grow faster, targeting 55–45 or 60–40 gas-to-liquid ratio over time.
Near-term Commissioning Windows
- JNPT Phase-1 liquid: Q1 FY27; revenue impact Q2 onwards.
- Pipavav liquid take-or-pay: Operations expected by year-end FY27.
- Kandla–Gorakhpur LPG pipeline: H1 FY27.
- Mangalore LPG rail gantry: “Should be earlier” than FY28 (no hard date).
7. Risks & Red Flags
- Capex execution risk at scale. USD 5bn by 2030 is 5x the typical annual capex run-rate. Management is banking on parent Aegis Logistics to build fast and cheap. That model works at ₹500–600 Cr/year; it’s untested at ₹10,000+ Cr/year.
- Vadhvan outlay contingent on approvals and land. INR 20,000 Cr is not trivial. If land allocation slips or regulatory clearance delays, the entire 2030 roadmap shifts. Management buried the contingency in passing.
- LPG import disruptions can repeat. The Strait of Hormuz is not getting safer. A 50% volume drop in March hit gas throughput hard. Normalization is assumed; another geopolitical shock would test that assumption quickly.
- Debt refinancing in a rising-rate environment. Interest expense fell because rates fell and capex-driven debt is now on refinanced longer tenor. If refinancing costs rise or capex accelerates faster than deleveraging, interest will creep back up.
- Pipavav port concession maturity in 2029. Management downplayed it (“long time to go”), but a 3-year runway on port concession renewal is not infinite optionality, especially if capex is being piled into the terminal.
- Return on capital questions. ROCE sits at 7.33%, ROE at 10% (LTM). Both are subpar for a ₹25,600 Cr market-cap company with a capex spree ahead. Management is betting new capacity will drive returns; the track record so far does not show explosive improvement.
8. Badi Badi Baatein Vadapao Khate, Will Management Walk the Talk?
The promise: 30–40% throughput growth, USD 5bn capex by 2030, gas dominance, new energy transitions (ammonia, cryogenic).
The track record (FY22 to FY26):
- Sales CAGR (3-year): 38%. ✓ They’ve delivered growth, though off a small base (FY23: ₹353 Cr).
- Profit CAGR (3-year): 1,472%. ✓ But this is misleading—FY23 was loss-making (₹-0.8/share); the denominator was tiny.
- Capex delivery: Liquid capacity 3.75x, LPG 4.5x since Nov 2021. ✓ They’ve scaled fast.
- Returns: ROCE has flat-lined at 7–8% over the period. ✗ More capacity, same return-on-capital. That’s a red flag.
What changed? Operating margins stayed flat (71–74%) despite capacity additions. Either utilization isn’t ramping as fast as capacity, or pricing is under pressure. Neither narrative supports the “30–40% growth” swagger.
The debt test: Gearing rose from 0.6x (FY23) to 0.87x (FY26), despite refinancing. If capex accelerates to ₹10,000 Cr/year, leverage will spike unless equity and operational cash flow both ramp. Management is counting on the latter; the jury is out.
9. EduInvesting Take
Strengths as facts:
- Capacity has scaled aggressively and on time; VLGC-compliant terminals are now operational (Kandla, Mangalore, Pipavav).
- Liquid throughput is growing faster (27.8%) than gas (8.6%), suggesting product mix is shifting toward higher-margin businesses.
- Take-or-pay contracts (15-year anchors at Pipavav liquid, Pipavav ammonia, Haldia LPG) provide revenue visibility and reduce commodity cycle risk.
- Parent company’s build capability (construct in-house via Aegis Logistics) is a genuine cost and speed advantage in a fragmented terminal market.
Weaknesses as facts:
- ROCE and ROE remain in the 7–10% range despite 3.75x capacity growth. New capacity is not yet translating to return expansion; utilization or pricing or both are lagging.
- LPG import disruptions (50% volume crater in March, partial recovery by May) showed the terminal business is not insulated from geopolitical and shipping volatility.
- Capex roadmap (USD 5bn by 2030) requires either a third equity raise or a material debt spike. Gearing is already 0.87x; management’s 0.6x target will require either lower capex or higher earnings—both uncertain.
- Dividend is negligible (2% yield on face), signalling cash is being hoarded for expansion. Shareholders are funding growth, not harvesting returns.
What to watch next quarter:
- JNPT liquid ramp: Is Phase-1 operational on schedule? Does “quite a good realization” materialize, or is pricing softer than claimed?
- Pipavav liquid utilization: The 15-year take-or-pay kicks in “by year-end.” How quickly does it ramp from day-one operations?
- LPG throughput recovery: Is the import environment normalizing from Q2 onwards, or are disruptions persisting?
- Capex spend vs. guidance: FY27 capex target is ~₹10,000 Cr. Is it tracking on pace, or are approvals/land delays pushing timelines?
- Ammonia terminal progress: Hindustan Zinc’s DAP plant is due H1 FY27. If the anchor customer delays, does the terminal still commission on time?
10. Conclusion
Aegis Vopak’s numbers are solid; its ambition is outsized. A 52% net profit jump is eye-catching until you subtract lower interest expense and realise operational leverage is modest. Capacity growth is real, but ROCE isn’t moving—a signal that new assets are being built to existing utilization and pricing, not to unlocking new economics. The capex roadmap is aggressive; the execution model is proven at smaller scale. By next year, we’ll know if management’s 30–40% growth thesis holds or if the terminal market is slower-growing and lower-returning than the hype suggests. For now: solid operations, aggressive capex, and returns that don’t yet justify the bet.
Written by EduInvesting Team
Sources: Aegis Vopak Terminals Ltd. – Q4 FY26 Earnings Concall Transcript (June 9, 2026); Screener Consolidated Financial Data (Profit & Loss, Balance Sheet, Cash Flow, Quarterly Results, Jun 2026).